Characteristics of controls and hypertriglyceridaemic patients at baseline and on bezafibrate and fish oil therapy
| Hypertriglyceridaemic patients | ||||
|---|---|---|---|---|
| Controls | Baseline | Bezafibrate | Fish oil | |
| Values are mean (SEM). | ||||
| *p≤0.05 compared with controls; †p≤0.05 compared with hypertriglyceridaemic patients at baseline; ‡p≤0.05 compared with hypertriglyceridaemic patients on bezafibrate. | ||||
| (V)LDL, (very) low density lipoprotein; HDL, high density lipoprotein. | ||||
| Age (y) | 51.9 (2.3) | 52.6 (2.7) | ||
| Body mass index (kg/m2) | 27.2 (0.9) | 27.8 (0.6) | 28.0 (0.7) | 28.2 (0.7) |
| Total cholesterol (mmol/l) | 5.20 (0.32) | 8.32 (1.31)* | 6.03 (0.54)† | 6.95 (1.16) |
| Total triglycerides (mmol/l) | 1.09 (0.21) | 15.56 (3.34) | 4.90 (1.31)† | 7.58 (2.85)† |
| VLDL cholesterol (mmol/l) | 0.29 (0.09) | 5.86 (1.28)* | 2.22 (0.60)† | 3.51 (1.09)† |
| VLDL triglycerides (mmol/l) | 0.72 (0.18) | 13.80 (3.19)* | 3.86 (1.22)† | 5.97 (2.09)†‡ |
| LDL cholesterol (mmol/l) | 3.98 (0.31) | 1.74 (0.22)* | 3.12 (0.29)† | 2.71 (0.26)† |
| HDL cholesterol (mmol/l) | 1.12 (0.07) | 0.63 (0.05)* | 0.74 (0.05) | 0.66 (0.05) |